Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
BMJ Case Rep ; 14(3)2021 Mar 23.
Artigo em Inglês | MEDLINE | ID: mdl-33758044

RESUMO

A 7-month-old female infant presented with failure to thrive. She was breastfed till 3 months of age, thereafter switched to soy-based milk formula. There was no history to suggest excess energy losses, recurrent infections or chronic diarrhoea. Three months after switching to exclusive soy-based milk formula, parents noticed significant enlargement of both breasts. Clinical examination was unremarkable except for enlargement of both breasts. None of the other secondary sexual characteristics were present. Initial blood investigations showed hyponatraemic hypokalaemic hypochloraemic metabolic alkalosis, which corrected after 2 days with intravenous hydration. The patient subsequently maintained normal electrolyte balance with recommended intake of cow's milk-based standard formula milk.Further exploration of her soy-based milk revealed that it was low in sodium and calories, unsuitable for children. This was not a standard and approved infant soy-based formula milk. She achieved excellent weight gain and reduction of breast size on cessation of soy-based milk formula.


Assuntos
Insuficiência de Crescimento , Hipersensibilidade a Leite , Animais , Aleitamento Materno , Bovinos , Criança , Insuficiência de Crescimento/etiologia , Feminino , Humanos , Lactente , Fórmulas Infantis , Leite
2.
BMJ Case Rep ; 12(8)2019 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-31439560

RESUMO

This case describes an uncommon presentation of herpes zoster in an adolescent with viral meningitis and concomitant genital shingles. A 15-year-old immunocompetent girl with background of well-controlled Graves' disease presented with 3 days of fever, frontal headache, terminal neck stiffness and photophobia. This was preceded by 4 days of pain and itch over vaginal and anal region. She had one dose of varicella vaccination at 18 months old and developed mild primary varicella infection around 5 years of age. Varicella zoster virus DNA was detected both in cerebrospinal fluid and in vesicles over her right labial majora. While there is no international consensus on the recommended duration of treatment for zoster with neurological complications, she was treated with intravenous acyclovir for 10 days with good clinical response. Her fever, headache and neck stiffness resolved after 2 days and genital lesions resolved after 9 days of antiviral therapy.


Assuntos
Doença de Graves , Herpes Zoster/diagnóstico , Herpesvirus Humano 3/isolamento & purificação , Meningite Viral/diagnóstico , Infecção pelo Vírus da Varicela-Zoster/diagnóstico , Aciclovir/administração & dosagem , Aciclovir/uso terapêutico , Adolescente , Antivirais/administração & dosagem , Antivirais/uso terapêutico , Diagnóstico Diferencial , Feminino , Genitália , Herpes Zoster/complicações , Herpes Zoster/tratamento farmacológico , Humanos , Meningite Viral/complicações , Meningite Viral/tratamento farmacológico , Infecção pelo Vírus da Varicela-Zoster/complicações , Infecção pelo Vírus da Varicela-Zoster/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa